A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma

Condition:   Asthma
Interventions:   Drug: CVT-301 (levodopa inhalation powder);   Drug: Carbidopa;   Other: Placebo
Sponsor:   Acorda Therapeutics
Recruiting – verified December 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days